Further corroboration of the onco-suppressive role of TMEFF2 in prostate cancer comes from the work of Georgescu et al. [62], who reported a positive correlation between high expression levels of TMEFF2 mRNA and recurrence-free survival of prostate cancer patients. The gene discussed is TMEFF2; the disease is prostate carcinoma.